首页> 外国专利> 3.beta-hydroxysteroid dehydrogenase in steroid dependent disease

3.beta-hydroxysteroid dehydrogenase in steroid dependent disease

机译:3.β-羟类固醇脱氢酶治疗类固醇依赖疾病

摘要

Methods and kits for characterizing a subject having a steroid-dependent disease such as prostate cancer are described. A method of treating a steroid-dependent disease in a subject by obtaining a biological sample from the subject, determining if the HSD3B1(1245C) gene or 3βHSD1(367T) protein is expressed in the biological sample, and providing treatment other than or in addition to steroid ablation to the subject if the HSD3B1(1245C) gene or 3βHSD1(367T) protein is expressed is also described.
机译:描述了用于表征患有类固醇依赖性疾病例如前列腺癌的受试者的方法和试剂盒。一种通过从受试者获得生物学样品,确定HSD3B1(1245C)基因或3βHSD1(367T)蛋白是否在生物学样品中表达,并提供除或之外的治疗方法来治疗受试者中类固醇依赖性疾病的方法还描述了如果表达HSD3B1(1245C)基因或3βHSD1(367T)蛋白对受试者的类固醇消融。

著录项

  • 公开/公告号US10533228B2

    专利类型

  • 公开/公告日2020-01-14

    原文格式PDF

  • 申请/专利权人 THE CLEVELAND CLINIC FOUNDATION;

    申请/专利号US201715712509

  • 发明设计人 NIMA SHARIFI;KAI-HSIUNG CHANG;

    申请日2017-09-22

  • 分类号C12Q1/68;G01N33/574;C12Q1/6886;A61K31/58;A61K31/4166;

  • 国家 US

  • 入库时间 2022-08-21 11:29:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号